In summary, miR-204’s regulation of genes such as COX5A and ERα plays a crucial role in influencing the chemoresistance of ER+ BC cells, making it a potential target for improving the effectiveness of chemotherapy in BC treatment. This evidence concerns the gene COX5A and breast cancer.